194 related articles for article (PubMed ID: 38072381)
1. Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study.
Poulsen MN; Roe SA; Asdell PB; Rahm AK; Berrettini W
J Subst Use Addict Treat; 2024 Mar; 158():209250. PubMed ID: 38072381
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
[TBL] [Abstract][Full Text] [Related]
3. Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study.
Poulsen MN; Asdell PB; Berrettini W; McBryan K; Rahm AK
SSM Ment Health; 2022 Dec; 2():. PubMed ID: 36776723
[TBL] [Abstract][Full Text] [Related]
4. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
[TBL] [Abstract][Full Text] [Related]
5. "It's a place that gives me hope": A qualitative evaluation of a buprenorphine-naloxone group visit program in an urban federally qualified health center.
Lai S; Li E; Silverio A; DeBates R; Kelly EL; Weinstein LC
Subst Abus; 2021; 42(4):858-864. PubMed ID: 33492204
[No Abstract] [Full Text] [Related]
6. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on APRN prescribing of medications for opioid use disorder: Key barriers remain.
Chapman SA; Fraimow-Wong L; Phoenix BJ; Tierney M; Spetz J
J Subst Use Addict Treat; 2024 Feb; 157():209215. PubMed ID: 37979946
[TBL] [Abstract][Full Text] [Related]
8. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions.
Chatterjee A; Baker T; Rudorf M; Walt G; Stotz C; Martin A; Kinnard EN; McAlearney AS; Bosak J; Medley B; Pinkhover A; Taylor JL; Samet JH; Lunze K
J Subst Use Addict Treat; 2024 Apr; 159():209272. PubMed ID: 38128649
[TBL] [Abstract][Full Text] [Related]
9. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
[TBL] [Abstract][Full Text] [Related]
10. Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults' Perspectives.
Bagley SM; Schoenberger SF; dellaBitta V; Lunze K; Barron K; Hadland SE; Park TW
J Adolesc Health; 2023 Jan; 72(1):105-110. PubMed ID: 36216678
[TBL] [Abstract][Full Text] [Related]
11. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
12. Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina.
Oros SM; Christon LM; Barth KS; Berini CR; Padgett BL; Diaz VA
Int J Psychiatry Med; 2021 Jan; 56(1):14-39. PubMed ID: 32726568
[TBL] [Abstract][Full Text] [Related]
13. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
Krawczyk N; Bandara S; Merritt S; Shah H; Duncan A; McEntee B; Schiff M; Ahmad NJ; Whaley S; Latimore A; Saloner B
Addict Sci Clin Pract; 2022 Jun; 17(1):30. PubMed ID: 35655293
[TBL] [Abstract][Full Text] [Related]
14. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
[TBL] [Abstract][Full Text] [Related]
15. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.
Morse E; Binswanger IA; Taylor E; Gray C; Stimmel M; Timko C; Harris AHS; Smelson D; Finlay AK
J Subst Abuse Treat; 2021 Oct; 129():108353. PubMed ID: 34080564
[TBL] [Abstract][Full Text] [Related]
16. Implementation of an office-based addiction treatment model for Medicaid enrollees: A mixed methods study.
Treitler P; Enich M; Bowden C; Mahone A; Lloyd J; Crystal S
J Subst Use Addict Treat; 2024 Jan; 156():209212. PubMed ID: 37935350
[TBL] [Abstract][Full Text] [Related]
17. Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.
Bart G; Korthuis PT; Donohue JM; Hagedorn HJ; Gustafson DH; Bazzi AR; Enns E; McNeely J; Ghitza UE; Magane KM; Baukol P; Vena A; Harris J; Voronca D; Saitz R
Addict Sci Clin Pract; 2024 Apr; 19(1):29. PubMed ID: 38600571
[TBL] [Abstract][Full Text] [Related]
18. Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.
Hawkins EJ; Danner AN; Malte CA; Blanchard BE; Williams EC; Hagedorn HJ; Gordon AJ; Drexler K; Burden JL; Knoeppel J; Lott A; Sayre GG; Midboe AM; Saxon AJ
Addict Sci Clin Pract; 2021 Sep; 16(1):55. PubMed ID: 34488892
[TBL] [Abstract][Full Text] [Related]
19. The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder.
Titus-Glover D; Shaya FT; Welsh C; Roane L
Subst Use Addctn J; 2024 Jul; 45(3):367-377. PubMed ID: 38254261
[TBL] [Abstract][Full Text] [Related]
20. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
Gustavson AM; Kenny ME; Wisdom JP; Salameh HA; Ackland PE; Gordon AJ; Hagedorn HJ
Addict Sci Clin Pract; 2021 Aug; 16(1):51. PubMed ID: 34362445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
